Clinical investigations have identified elevated serum ANGPTL8 levels in individuals with liver fibrosis and liver cancer (Vatner et al., 2018; Pazgan-Simon et al., 2020; Wang et al., 2018). This evidence concerns the gene ANGPTL8 and liver cancer.